The session features a trio of key executives: Executive Vice President and Chief Financial Officer Thomas Dittrich, Chief Medical Officer Paul Burton, and Kave Niksefat, who leads Global Marketing and Access. Their participation highlights Amgen’s ongoing efforts to communicate business developments and pipeline progress to the investment community.

Interested parties can access the broadcast through the Amgen website, where it will remain archived for at least 90 days. The event serves as part of the company's broader strategy to maintain transparency regarding its portfolio, which spans treatments for oncology, cardiology, inflammatory disorders, and obesity-related conditions.